Literature DB >> 22689497

Response to pretreatment with low-dose β-adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy.

Yoshihiro J Akashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22689497      PMCID： PMC6652492          DOI： 10.1002/clc.22006

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


× No keyword cloud information.
  4 in total

1.  Cardiac and vascular gene profiles in an animal model of takotsubo cardiomyopathy.

Authors:  Takashi Ueyama; Yuta Yamamoto; Kazuki Ueda; Tetsuya Kawabe; Takuzo Hano; Takao Ito; Yoshihiro Tsuruo; Masao Ichinose; Ken-ichi Yoshida
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

2.  Pretreatment with low-dose β-adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy.

Authors:  Amruth R Palla; Amit S Dande; Joann Petrini; Hal S Wasserman; Mark K Warshofsky
Journal:  Clin Cardiol       Date:  2012-03-23       Impact factor: 2.882

3.  Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Authors:  Scott W Sharkey; Denise C Windenburg; John R Lesser; Martin S Maron; Robert G Hauser; Jennifer N Lesser; Tammy S Haas; James S Hodges; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

Review 4.  Takotsubo cardiomyopathy: a new form of acute, reversible heart failure.

Authors:  Yoshihiro J Akashi; David S Goldstein; Giuseppe Barbaro; Takashi Ueyama
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690
  4 in total
  1 in total

Review 1.  "Reverse McConnell's Sign": Interpreting Interventricular Hemodynamic Dependency and Guiding the Management of Acute Heart Failure during Takotsubo Cardiomyopathy.

Authors:  Kan Liu; Zhongxia Sun; Tiemin Wei
Journal:  Clin Med Insights Cardiol       Date:  2015-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.